Genetic influences on the neural and physiological bases of acute threat: A research domain criteria (RDoC) perspective

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 171, Issue 1, 2016, Pages 44-64

  Sumner, Jennifer A ^a,b   Powers, Abigail ^c   Jovanovic, Tanja ^c   Koenen, Karestan C ^b,d,e  

^a Department of Medicine   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e BROAD INSTITUTE OF MIT AND HARVARD   (United States)

Author keywords

Acute threat; Genetics; Neural circuit; Physiology; RDoC

Indexed keywords

CATECHOL METHYLTRANSFERASE; SEROTONIN TRANSPORTER;

ACUTE STRESS; ANXIETY; ARTICLE; BRAIN DEPTH STIMULATION; COMT GENE; CONCEPTUAL FRAMEWORK; FEAR; FRONTAL CORTEX; GENE IDENTIFICATION; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC DISORDER; GENOME ANALYSIS; GENOMICS; HEART RATE; HEREDITY; HERITABILITY; HUMAN; LIMBIC SYSTEM; MENTAL DISEASE; MENTAL FUNCTION; MOLECULAR GENETICS; NEUROANATOMY; NEUROPHYSIOLOGY; NEUROPSYCHIATRY; NONHUMAN; PRIORITY JOURNAL; PSYCHOTRAUMA; SKIN CONDUCTANCE; SLC6A4 GENE; STARTLE REFLEX; TRANSLATIONAL RESEARCH; ANIMAL; ANXIETY DISORDER; GENETICS; GENOME-WIDE ASSOCIATION STUDY; NATIONAL HEALTH ORGANIZATION; NERVE TRACT; PATHOPHYSIOLOGY; PHYSIOLOGY; RESEARCH; UNITED STATES;

ANIMALS; ANXIETY DISORDERS; GENOME-WIDE ASSOCIATION STUDY; HUMANS; NATIONAL INSTITUTE OF MENTAL HEALTH (U.S.); NEURAL PATHWAYS; RESEARCH; UNITED STATES;

EID: 84954376015     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.32384     Document Type: Article

References (163)

1. Agren T, Furmark T, Eriksson E, Fredrikson M. 2012. Human fear reconsolidation and allelic differences in serotonergic and dopaminergic genes. Transl Psychiatry 2:e76.
2. Amé JC, Spenlehauer C, de Murcia G. 2004. The PARP superfamily. Bioessays 26:882-893.
3. Andero R, Brothers SP, Jovanovic T, Chen YT, Salah-Uddin H, Cameron M, Bannister TD, Almli L, Stevens JS, Bradley B, Binder EB, Wahlestedt C, Ressler KJ. 2013. Amygdala-dependent fear is regulated by Oprl1 in mice and humans with PTSD. Sci Transl Med 5:188ra73.
4. Anokhin AP, Golosheykin S, Heath AC. 2007. Genetic and environmental influences on emotion-modulated startle reflex: A twin study. Psychophysiology 44:106-112.
5. Anokhin AP, Heath AC, Myers E, Ralano A, Wood S. 2003. Genetic influences on prepulse inhibition of startle reflex in humans. Neurosci Lett 15:45-48.
6. Armbruster D, Moser DA, Strobel A, Hensch T, Kirschbaum C, Lesch K-P, Brocke B. 2009. Serotonin transporter gene variation and stressful life events impact processing of fear and anxiety. Int J Neuropsychopharmacol 12:393-401.
7. Asghari V, Sanyal S, Buchwaldt S, Paterson A, Jovanovic V, Van Tol HH. 1995. Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants. J Neurochem 65:1157-1165.
8. Baas JM. 2013. Individual differences in predicting aversive events and modulating contextual anxiety in a context and cue conditioning paradigm. Biol Psychol 92:17-25.
9. Baas JM, Heitland I. The impact of cue learning, trait anxiety and genetic variation in the serotonin 1a receptor on contextual fear [published online ahead of print November 6, 2014]. Int J Psychophysiol doi: 10.1016/j.ijpsycho. 2014.10.016.
10. Bath KG, Lee FS. 2006. Variant BDNF (val66met) impact on brain structure and function. Cogn Affect Behav Neurosci 6:79-85.
11. Bertolino A, Arciero G, Rubino V, Latorre V, De Candia M, Mazzola V, Blasi G, Caforio G, Hariri A, Kolachana B, Nardini M, Weinberger DR, Scarabino T. 2005. Variation of human amygdala response during threatening stimuli as a function of 5'HTTLPR genotype and personality style. Biol Psychiatry 57:1517-1525.
12. Bilkei-Gorzo A, Erk S, Schürmann B, Mauer D, Michel K, Boecker H, Scheef L, Walter H, Zimmer A. 2012. Dynorphins regulate fear memory: from mice to men. J Neurosci 32:9335-9343.
13. Blokland GAM, de Zubicaray GI, McMahon KL, Wright MJ. 2012. Genetic and environmental influences on neuroimaging phenotypes: A meta-analytical perspective on twin imaging studies. Twin Res Hum Genet 15:351-371.
14. Blokland GAM, McMahon KL, Thompson PM, Martin NG, de Zubicaray GI, Wright MJ. 2011. Heritability of working memory brain activation. J Neurosci 31:10882-10890.
15. Briscione MA, Jovanovic T, Norrholm SD. 2014. Conditioned fear associated phenotypes as robust, translational indices of trauma-, stressor-, and anxiety-related behaviors. Front Psychiatry 5:88.
16. Brocke B, Armbruster D, Müller J, Hensch T, Jacob CP, Lesch K-P, Kirschbaum C, Strobel A. 2006. Serotonin transporter gene variation impacts innate fear processing: Acoustic startle response and emotional startle. Mol Psychiatry 11:1106-1112.
17. Brocke B, Lesch K-P, Armbruster D, Moser DA, Müller A, Strobel A, Kirschbaum C. 2010. Stathmin, a gene regulating neural plasticity, affects fear and anxiety processing in humans. Am J Med Genet B Neuropsychiatr Genet 153B:243-251.
18. Brown SM, Peet E, Manuck SB, Williamson DE, Dahl RE, Ferrell RE, Hariri AR. 2005. A regulatory variant of the human tryptophan hydroxylase-2 gene biases amygdala reactivity. Mol Psychiatry 10:884-888.
19. Cacciaglia R, Nees F, Pohlack ST, Ruttorf M, Winkelmann T, Witt SH, Nieratschker V, Rietschel M, Flor H. 2013. A risk variant for alcoholism in the NMDA receptor affects amygdala activity during fear conditioning in humans. Biol Psychol 94:74-81.
20. Canli T, Congdon E, Constable RT, Lesch KP. 2008. Additive effects of serotonin transporter and tryptophan hydroxylase-2 gene variation on neural correlates of affective processing. Biol Psychol 79:118-125.
21. Canli T, Congdon E, Gutknecht L, Constable RT, Lesch KP. 2005. Amygdala responsiveness is modulated by tryptophan hydroxylase-2 gene variation. J Neural Transm 112:1479-1485.
22. Canli T, Omura K, Haas BW, Fallgatter A, Constable RT, Lesch KP. 2005. Beyond affect: a role for genetic variation of the serotonin transporter in neural activation during a cognitive attention task. Proc Natl Acad Sci USA 102:12224-12229.
23. Canli T, Qui M, Omura K, Congdon E, Haas BW, Amin Z, Herrmann MJ, Constable RT, Lesch KP. 2006. Neural correlates of epigenesis. Proc Natl Acad Sci USA 103:16033-16038.
24. Carlson SR, Katsanis J, Iacono WG, McGue M. 1997. Emotional modulation of the startle reflex in twins: Preliminary findings. Biol Psychol 46:235-246.
25. Chiodo K. NIMH creates new unit to support its research domain criteria initiative. National Institute of Mental Health. http://www.nimh.nih.gov/news/science-news/2014/nimh-creates-new-unit-to-support-its-research-domain-criteria-initiative.shtml Published October 30, 2014 Accessed February 28, 2015.
26. Crisan LG, Pana S, Vulturar R, Heilman RM, Szekely R, Druga B, Dragos N, Miu AC. 2009. Genetic contributions of the serotonin transporter to social learning of fear and economic decision making. SCAN 4:399-408.
27. Critchley HD, Rotshtein P, Nagai Y, O'Doherty J, Mathias CJ, Dolan RJ. 2005. Activity in the human brain predicting differential heart rate responses to emotional facial expressions. Neuroimage 24:751-762.
28. Cross-Disorder Group of the Psychiatric Genomics Consortium . 2013. Identification of risk loci with shared effects on five major psychiatric disorders: A genome-wide analysis. Lancet 381:1371-1379.
29. Cuthbert BN, Insel TR. 2013. Toward the future of psychiatric diagnosis: The seven pillars of RDoC. BMC Med 11:126.
30. Dannlowski U, Kugel H, Franke F, Stuhrmann A, Hohoff C, Zwanzger P, Lenzen T, Grotegerd D, Suslow T, Arolt V, Heindel W, Domschke K. 2011. Neuropeptide-S (NPS) receptor genotype modulates basolateral amygdala responsiveness to aversive stimuli. Neuropsychopharmacology 36:1879-1885.
31. Davis M. 1992. The role of the amygdala in fear-potentiated startle: Implications for animal models of anxiety. Trends Pharmacol Sci 13:35-41.
32. Davis M, Gendelman D, Tischler M, Gendelman P. 1982. A primary acoustic startle circuit: lesion and stimulation studies. J Neurosci. 2:791-805.
33. Davis M, Walker D, Lee Y. 1997. Roles of the amygdala and bed nucleus of the stria terminalis in fear and anxiety measured with the acoustic startle reflex. Possible relevance to PTSD. Ann N Y Acad Sci 821:305-331.
34. de Geus EJ, Kupper N, Boomsma DI, Snieder H. 2007. Bivariate genetic modeling of cardiovascular stress reactivity: Does stress uncover genetic variance?. Psychosom Med 69:356-364.
35. Deckert J, Catalano M, Syagailo YV, Bosi M, Okladnova O, Di Bella D, Nöthen MM, Maffei P, Franke P, Fritze J, Maier W, Propping P, Beckmann H, Bellodi L, Lesch KP. 1999. Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Hum Mol Genet 8:621-624.
36. Domschke K, Ohrmann P, Braun M, Suslow T, Bauer J, Hohoff C, Kersting A, Engelien A, Arolt V, Heindel W, Deckert J, Kugel H. 2008. Influence of the catechol-O-methyltransferase val158met genotype on amygdala and prefrontal cortex emotional processing in panic disorder. Psychiatry Res 163:13-20.
37. Domschke K, Reif A, Weber H, Richter J, Hohoff C, Ohrmann P, Pedersen A, Bauer J, Suslow T, Kugel H, Heindel W, Baumann C, Klauke B, Jacob C, Maier W, Fritze J, Bandelow B, Krakowitzky P, Rothermundt M, Erhardt A, Binder EB, Holsboer F, Gerlach AL, Kircher T, Lang T, Alpers GW, Ströhle A, Fehm L, Gloster AT, Wittchen HU, Arolt V, Pauli P, Hamm A, Deckert J. 2011. Neuropeptide S receptor gene-converging evidence for a role in panic disorder. Mol Psychiatry 16:938-948.
38. Drabant EM, Hariri AR, Meyer-Lindenberg A, Munoz KE, Mattay VS, Kolachana BS, Egan MF, Weinberger DR. 2006. Catechol O-methyltransferase val158met genotype and neural mechanisms related to affective arousal and regulation. Arch Gen Psychiatry 63:1396-1406.
39. Drabant EM, Ramel W, Edge MD, Hyde LW, Kuo JR, Goldin PR, Hariri AR, Gross JJ. 2012. Neural mechanisms underlying 5-HTTLPR-related sensitivity to acute stress. Am J Psychiatry 169:397-405.
40. Duits PM, Cath DC, Lissek S, Hox JJ, Hamm AO, Engelhard IM, van den Hout MA, Baas JM. 2015. Updated meta-analysis of classical fear conditioning in the anxiety disorders. Depress Anxiety 32:239-253.
41. Egan MF, Kojirna M, Callicott JH, Goldberg TE, Kolachana BS, Bertolino A, Zaitsev E, Gold B, Goldman D, Dean M, Lu B, Weinberger DR. 2003. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112:257-269.
42. Fadok JP, Dickerson TMK, Palmiter RD. 2009. Dopamine is necessary for cue-dependent fear conditioning. J Neurosci 29:11089-11097.
43. Fakra E, Hyde LW, Gorka A, Fisher PM, Muñoz KE, Kimak M, Halder I, Ferrell RE, Manuck SB, Hariri AR. 2009. Effects of HTR1A C(-1019)G on amygdala reactivity and trait anxiety. Arch Gen Psychiatry 66:33-40.
44. Fisher PM, Hariri AR. 2013. Identifying serotonergic mechanisms underlying the corticolimbic response to threat in humans. Philos Trans R Soc Lond B Biol Sci 368:20120192.
45. Fisher PM, Muñoz KE, Hariri AR. 2008. Identification of neurogenetic pathways of risk for psychopathology. Am J Med Genet Part C Semin Med Genet 148C:147-153.
46. Flint J, Munafò MR. 2007. The endophenotype concept in psychiatric genetics. Psychol Med 37:163-180.
47. Furmark T, Tillfors M, Garpenstrand H, Marteinsdottir I, Långström B, Oreland L, Fredrikson M. 2004. Serotonin transporter polymorphism related to amygdala excitability and symptom severity in patients with social phobia. Neurosci Lett 362:189-192.
48. Garpenstrand H, Annas P, Ekblom J, Oreland L, Fredrikson M. 2001. Human fear conditioning is related to dopaminergic and serotonergic biological markers. Behav Neurosci 115:358-364.
49. Gatt JM, Nemeroff CB, Dobson-Stone C, Paul RH, Bryant RA, Schofield PR, Gordon E, Kemp AH, Williams LM. 2009. Interactions between BDNF Val66Met polymorphism and early life stress predict brain and arousal pathways to syndromal depression and anxiety. Mol Psychiatry 14:681-695.
50. Gatt JM, Nemeroff CB, Schofield PR, Paul RH, Clark CR, Gordon E, Williams LM. 2010. Early life stress combined with serotonin 3A receptor and brain-derived neurotrophic factor valine 66 to methionine genotypes impacts emotional brain and arousal correlates of risk for depression. Biol Psychiatry 68:818-824.
51. Glotzbach-Schoon E, Andreatta M, Reif A, Ewald H, Tröger C, Baumann C, Deckert J, Mühlberger A, Pauli P. 2013. Contextual fear conditioning in virtual reality is affected by 5HTTLPR and NPSR1 polymorphisms: effects on fear-potentiated startle. Front Behav Neurosci 7:31.
52. Grillon C, Ameli R. 1998. Effects of threat of shock, shock electrode placement and darkness on startle. Int J Psychophysiol 28:223-231.
53. Gunduz-Cinar O, MacPherson KP, Cinar R, Gamble-George J, Sugden K, Williams B, Godlewski G, Ramikie TS, Gorka AX, Alapafuja SO, Nikas SP, Makriyannis A, Poulton R, Patel S, Hariri AR, Caspi A, Moffitt TE, Kunos G, Holmes A. 2013. Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity. Mol Psychiatry 18:813-823.
54. Hajcak G, Castille C, Olvet DM, Dunning JP, Roohi J, Hatchwell E. 2009. Genetic variation in brain-derived neurotrophic factor and human fear conditioning. Genes Brain Behav 8:80-85.
55. Hamm AO, Weike AI. 2005. The neuropsychology of fear learning and fear regulation. Int J Psychophysiol 57:5-14.
56. Hariri AR, Gorka A, Hyde LW, Kimak M, Halder I, Ducci F, Ferrell RE, Goldman D, Manuck SB. 2009. Divergent effects of genetic variation in endocannabinoid signaling on human threat- and reward related brain function. Biol Psychiatry 66:9-16.
57. Hariri AR, Mattay VS, Tessitore A, Kolachana B, Fera F, Goldman D, Egan MF, Weinberger DR. 2002. Serotonin transporter genetic variation and the response of the human amygdala. Science. 297:400-403.
58. Hartley CA, McKenna MC, Salman R, Holmes A, Casey BJ, Phelps EA, Glatt CE. 2012. Serotonin transporter polyadenylation polymorphism modulates the retention of fear extinction memory. Proc Natl Acad Sci USA 109:5493-5498.
59. Heinz A, Braus DF, Smolka MN, Wrase J, Puls I, Hermann D, Klein S, Grüsser SM, Flor H, Schumann G, Mann K, Büchel C. 2005. Amygdala-prefrontal coupling depends on a genetic variation of the serotonin transporter. Nat Neurosci 8:20-21.
60. Heitland I, Groenink L, Bijlsma EY, Oosting RS, Baas JM. 2013. Human fear acquisition deficits in relation to genetic variants of the corticotropin releasing hormone receptor 1 and the serotonin transporter. PLoS One 8:e63772.
61. Heitland I, Klumpers F, Oosting RS, Evers DJJ, Kenemans JL, Baas JMP. 2012. Failure to extinguish fear and genetic variability in the human cannabinoid receptor 1. Transl Psychiatry 2:e162.
62. Hermann A, Küpper Y, Schmitz A, Walter B, Vaitl D, Hennig J, Stark R, Tabbert K. 2012. Functional gene polymorphisms in the serotonin system and traumatic life events modulate the neural basis of fear acquisition and extinction. PLoS One 7:e44352.
63. Hettema JM, Annas P, Neale MC, Kendler KS, Fredrikson M. 2003. A twin study of the genetics of fear conditioning. Arch Gen Psychiatry 60:702-708.
64. Hibar DP, Stein JL, Renteria ME, Arias-Vasquez A, Desrivieres S, Jahanshad N, Toro R, Wittfeld K, Abramovic L, Andersson M, Aribisala BS, Armstrong NJ, Bernard M, Bohlken MM, Boks MP, Bralten J, Brown AA, Mallar Chakravarty M, Chen Q, Ching CR, Cuellar-Partida G, den Braber A, Giddaluru S, Goldman AL, Grimm O, Guadalupe T, Hass J, Woldehawariat G, Holmes AJ, Hoogman M, Janowitz D, Jia T, Kim S, Klein M, Kraemer B, Lee PH, Olde Loohuis LM, Luciano M, Macare C, Mather KA, Mattheisen M, Milaneschi Y, Nho K, Papmeyer M, Ramasamy A, Risacher SL, Roiz-Santianez R, Rose EJ, Salami A, Samann PG, Schmaal L, Schork AJ, Shin J, Strike LT, Teumer A, van Donkelaar MM, van Eijk KR, Walters RK, Westlye LT, Whelan CD, Winkler AM, Zwiers MP, Alhusaini S, Athanasiu L, Ehrlich S, Hakobjan MM, Hartberg CB, Haukvik UK, Heister AJ, Hoehn D, Kasperaviciute D, Liewald DC, Lopez LM, Makkinje RR, Matarin M, Naber MA, Reese McKay D, Needham M, Nugent AC, Putz B, Royle NA, Shen L, Sprooten E, Trabzuni D, van der Marel SS, van Hulzen KJ, Walton E, Wolf C, Almasy L, Ames D, Arepalli S, Assareh AA, Bastin ME, Brodaty H, Bulayeva KB, Carless MA, Cichon S, Corvin A, Curran JE, Czisch M, de Zubicaray GI, Dillman A, Duggirala R, Dyer TD, Erk S, Fedko IO, Ferrucci L, Foroud TM, Fox PT, Fukunaga M, Raphael Gibbs J, Goring HH, Green RC, Guelfi S, Hansell NK, Hartman CA, Hegenscheid K, Heinz A, Hernandez DG, Heslenfeld DJ, Hoekstra PJ, Holsboer F, Homuth G, Hottenga JJ, Ikeda M, Jack CR, Jr., Jenkinson M, Johnson R, Kanai R, Keil M, Kent JW, Jr., Kochunov P, Kwok JB, Lawrie SM, Liu X, Longo DL, McMahon KL, Meisenzahl E, Melle I, Mohnke S, Montgomery GW, Mostert JC, Muhleisen TW, Nalls MA, Nichols TE, Nilsson LG, Nothen MM, Ohi K, Olvera RL, Perez-Iglesias R, Bruce Pike G, Potkin SG, Reinvang I, Reppermund S, Rietschel M, Romanczuk-Seiferth N, Rosen GD, Rujescu D, Schnell K, Schofield PR, Smith C, Steen VM, Sussmann JE, Thalamuthu A, Toga AW, Traynor BJ, Troncoso J, Turner JA, Valdes Hernandez MC, van 't Ent D, van der Brug M, van der Wee NJ, van Tol MJ, Veltman DJ, Wassink TH, Westman E, Zielke RH, Zonderman AB, Ashbrook DG, Hager R, Lu L, McMahon FJ, Morris DW, Williams RW, Brunner HG, Buckner RL, Buitelaar JK, Cahn W, Calhoun VD, Cavalleri GL, Crespo-Facorro B, Dale AM, Davies GE, Delanty N, Depondt C, Djurovic S, Drevets WC, Espeseth T, Gollub RL, Ho BC, Hoffmann W, Hosten N, Kahn RS, Le Hellard S, Meyer-Lindenberg A, Muller-Myhsok B, Nauck M, Nyberg L, Pandolfo M, Penninx BW, Roffman JL, Sisodiya SM, Smoller JW, van Bokhoven H, van Haren NE, Volzke H, Walter H, Weiner MW, Wen W, White T, Agartz I, Andreassen OA, Blangero J, Boomsma DI, Brouwer RM, Cannon DM, Cookson MR, de Geus EJ, Deary IJ, Donohoe G, Fernandez G, Fisher SE, Francks C, Glahn DC, Grabe HJ, Gruber O, Hardy J, Hashimoto R, Hulshoff Pol HE, Jonsson EG, Kloszewska I, Lovestone S, Mattay VS, Mecocci P, McDonald C, McIntosh AM, Ophoff RA, Paus T, Pausova Z, Ryten M, Sachdev PS, Saykin AJ, Simmons A, Singleton A, Soininen H, Wardlaw JM, Weale ME, Weinberger DR, Adams HH, Launer LJ, Seiler S, Schmidt R, Chauhan G, Satizabal CL, Becker JT, Yanek L, van der Lee SJ, Ebling M, Fischl B, Longstreth WT, Jr., Greve D, Schmidt H, Nyquist P, Vinke LN, van Duijn CM, Xue L, Mazoyer B, Bis JC, Gudnason V, Seshadri S, Arfan Ikram M, The Alzheimer's Disease Neuroimaging I, The CC, Epigen, Imagen, Sys, Martin NG, Wright MJ, Schumann G, Franke B, Thompson PM, Medland SE. 2015. Common genetic variants influence human subcortical brain structures. Nature 520:224-229.
65. Homberg JR, Lesch KP. 2011. Looking on the bright side of serotonin transporter gene variation. Biol Psychiatry 69:513-519.
66. Homberg JR, Molteni R, Calabrese F, Riva MA. 2014. The serotonin-BDNF duo: Developmental implications for the vulnerability to psychopathology. Neurosci Biobehav Rev 43:35-47.
67. Hotamisligil GS, Breakefield XO. 1991. Human monoamine oxidase A gene determines levels of enzyme activity. Am J Hum Genet 49:383-392.
68. Hu XZ, Lipsky RH, Zhu G, Akhtar LA, Taubman J, Greenberg BD, Xu K, Arnold PD, Richter MA, Kennedy JL, Murphy DL, Goldman D. 2006. Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. Am J Hum Genet 78:815-826.
69. Huertas E, Ponce G, Koeneke MA, Poch C, España-Serrano L, Palomo T, Jiménez-Arriero MA, Hoenicka J. 2010. The D2 dopamine receptor gene variantC957T affects human fear conditioning and aversive priming. Genes Brain Behav 9:103-109.
70. Institute of Medicine . 2008. Treatment of posttraumatic stress disorder: an assessment of the evidence. Washington, DC: The National Academies Press.
71. International Schizophrenia Consortium, Purcell SM, Wray NR, Stone JL, Visscher PM, O'Donovan MC, Sullivan PF, Sklar P. 2009. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460:748-752.
72. Jovanovic T, Norrholm SD, Davis J, Mercer KB, Almli L, Nelson A, Cross D, Smith A, Ressler KJ, Bradley B. 2013. PAC1 receptor (ADCYAP1R1) genotype is associated with dark-enhanced startle in children. Mol Psychiatry 18:742-743.
73. Kempton MJ, Haldane M, Jogia J, Christodoulou T, Powell J, Collier D, Williams SC, Frangou S. 2008. The effects of gender and COMT Val158Met polymorphism on fearful facial affect recognition: a fMRI study. Int J Neuropsychopharmacol 12:371-381.
74. Kendler K. 2013. What psychiatric genetics has taught us about the nature of psychiatric illness and what is left to learn. Mol Psychiatry 18:1058-1066.
75. Kendler K, Eaves LJ. 2005. Psychiatric genetics (review of psychiatry). Washington, DC: American Psychiatric Press.
76. Klauke B, Winter B, Gajewska A, Zwanzger P, Reif A, Herrmann MJ, Dlugos A, Warrings B, Jacob C, Mühlberger A, Arolt V, Pauli P, Deckert J, Domschke K. 2012. Affect-modulated startle: Interactive influence of catechol-O-methyltransferase Val158Met genotype and childhood trauma. PLoS One 7:e39709.
77. Klucken T, Alexander N, Schweckendiek J, Merz CJ, Kagerer S, Osinsky R, Walter B, Vaitl D, Hennig J, Stark R. 2013. Individual differences in neural correlates of fear conditioning as a function of 5-HTTLPR and stressful life events. Soc Cogn Affect Neurosci 8:318-325.
78. Klucken T, Schweckendiek J, Blecker C, Walter B, Kuepper Y, Hennig J, Stark R. 2014. The association between the 5-HTTLPR and neural correlates of fear conditioning and connectivity. Soc Cogn Affect Neurosci 10:700-707.
79. Klumpers F, Heitland I, Oosting RS, Kenemans JL, Baas JM. 2012. Genetic variation in serotonin transporter function affects human fear expression indexed by fear-potentiated startle. Biol Psychol 89:277-282.
80. Klumpers F, Kroes MC, Heitland I, Everaerd D, Akkermans SE, Oosting RS, van Wingen G, Franke B, Kenemans JL, Fernández G, Baas JM. 2014. Dorsomedial prefrontal cortex mediates the impact of serotonin transporter linked polymorphic region genotype on anticipatory threat reactions. Biol Psychiatry Advance online publication. DOI: 10.1016/j.biopsych.2014.07.034.
81. Koten JW, Jr, Wood G, Hagoort P, Goebel R, Propping P, Willmes K, Boomsma DI. 2009. Genetic contribution to variation in cognitive function: An FMRI study in twins. Science 323:1737-1740.
82. Lang PJ, Bradley MM, Cuthbert BN. 1990. Emotion, attention, and the startle reflex. Psychol Rev 97:377-395.
83. Lang PJ, Bradley MM, Cuthbert BN. 1999. The International Affective Picture System (IAPS). Gainesville, FL: Center for Research in Psychophysiology, University of Florida.
84. Larson CL, Taubitz LE, Robinson JS. 2010. MAOA T941G polymorphism and the time course of emotional recovery following unpleasant pictures. Psychophysiology 47:857-862.
85. Lau JYF, Goldman D, Buzas B, Hodgkinson C, Leibenluft E, Nelson E, Sankin L, Pine DS, Ernst M. 2010. BDNF gene polymorphism (Val66Met) predicts amygdala and anterior hippocampus responses to emotional faces in anxious and depressed adolescents. Neuroimage 53:952-961.
86. Lemonde S, Turecki G, Bakish D, Du L, Hrdina PD, Bown CD, Sequeira A, Kushwaha N, Morris SJ, Basak A, Ou XM, Albert PR. 2003. Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide. J Neurosci 23:8788-8799.
87. Lissek S, Powers AS, McClure EB, Phelps EA, Woldehawariat G, Grillon C, Pine DS. 2005. Classical fear conditioning in the anxiety disorders: A meta-analysis. Behav Res Ther 43:1391-1424.
88. Lissek S, Rabin S, Heller RE, Lukenbaugh D, Geraci M, Pine DS, Grillon C. 2010. Overgeneralization of conditioned fear as a pathogenic marker of panic disorder. Am J Psychiatry 167:47-55.
89. Logue MW, Amstadter AB, Baker DG, Duncan L, Koenen KC, Liberzon I, Miller MW, Morey RA, Nievergelt CM, Ressler KJ, Smith AK, Smoller JW, Stein MB, Sumner JA, Uddin M. 2015. Advance online publication The Psychiatric Genomics Consortium posttraumatic stress disorder workgroup: Posttraumatic stress disorder enters the age of large-scale genomic collaboration. Neuropsychopharmacology DOI: 10.1038/npp.2015.118.
90. Lonsdorf TB, Golkar A, Lindstöm KM, Fransson P, Schalling M, Ohman A, Ingvar M. 2011. 5-HTTLPR and COMTval158met genotype gate amygdala reactivity and habituation. Biol Psychol 87:106-112.
91. Lonsdorf TB, Golkar A, Lindström KM, Haaker J, Ohman A, Schalling M, Ingvar M. 2014. BDNFval66met affects neural activation pattern during fear conditioning and 24h delayed fear recall. Soc Cogn Affect Neurosci 10:664-671.
92. Lonsdorf TB, Kalisch R. 2011. A review on experimental and clinical genetic associations studies on fear conditioning, extinction and cognitive-behavioral treatment. Transl Psychiatry 1:e41.
93. Lonsdorf TB, Weike AI, Golkar A, Schalling M, Hamm AO, Ohman A. 2010. Amygdala-dependent fear conditioning in humans is modulated by the BDNFval66met polymorphism. Behav Neurosci 124:9-15.
94. Lonsdorf TB, Weike AI, Nikamo P, Schalling M, Hamm AO, Ohman A. 2009. Genetic gating of human fear learning and extinction: possible implications for gene-environment interactions in anxiety disorder. Psychol Sci 20:198-206.
95. Lueken U, Straube B, Konrad C, Wittchen HU, Ströhle A, Wittmann A, Pfleiderer B, Uhlmann C, Arolt V, Jansen A, Kircher T. 2013. Neural substrates of treatment response to cognitive-behavioral therapy in panic disorder with agoraphobia. Am J Psychiatry 170:1345-1355.
96. Lueken U, Straube B, Wittchen HU, Konrad C, Ströhle A, Wittmann A, Pfleiderer B, Arolt V, Kircher T, Deckert J, Reif A. 2015. Therapygenetics: Anterior cingulate cortex-amygdala coupling is associated with 5-HTTLPR and treatment response in panic disorder with agoraphobia. J Neural Transm 122:135-144.
97. Lykken DT, Venables PH. 1971. Direct measurement of skin conductance: A proposal for standardization. Psychophysiology 8:656-672.
98. Mannisto P, Kaakkola S. 1999. Catchol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. Pharmacol Rev 51:593-628.
99. Manuck SB, Brown SM, Forbes EE, Hariri AR. 2007. Temporal stability of individual differences in amygdala reactivity. Am J Psychiatry 164:1613-1614.
100. Maren S. 2001. Neurobiology of Pavlovian fear conditioning. Annu Rev Neurosci 24:897-931.
101. Meyer-Lindenberg A, Buckholtz JW, Kolachana B, Hariri RA, Pezawas L, Blasi G, Wabnitz A, Honea R, Verchinski B, Callicott JH, Egan M, Mattay V, Weinberger DR. 2006. Neural mechanisms of genetic risk for impulsivity and violence in humans. Proc Natl Acad Sci USA 103:6269-6274.
102. Meyer-Lindenberg A, Kolachana B, Gold B, Olsh A, Nicodemus KK, Mattay V, Dean M, Weinberger DR. 2009. Genetic variants in AVPR1A linked to autism predict amygdala activation and personality traits in healthy humans. Mol Psychiatry 14:968-975.
103. Meyer-Lindenberg A, Weinberger DR. 2006. Intermediate phenotypes and genetic mechanisms of psychiatric disorders. Nat Rev Neurosci 7:818-827.
104. Milad MR, Wright CI, Orr SP, Pitman RK, Quirk GJ, Rauch SL. 2007. Recall of fear extinction in humans activates the ventromedial prefrontal cortex and hippocampus in concert. Biol Psychiatry 62:446-454.
105. Miskowiak KW, Glerup L, Vestbo C, Harmer CJ, Reinecke A, Macoveanu J, Siebner HR, Kessing LV, Vinberg M. 2014. Different neural and cognitive response to emotional faces in healthy monozygotic twins at risk of depression. Psychol Med 45:1447-1458.
106. Montag C, Buckholtz JW, Hartmann P, Merz M, Burk C, Hennig J, Reuter M. 2008. COMT genetic variation affects fear processing: Psychophysiological evidence. Behav Neurosci 122:901-909.
107. Morris SE, Cuthbert BN. 2012. Research Domain Criteria: Cognitive systems, neural circuits, and dimensions of behavior. Dialogues Clin Neurosci 14:29-37.
108. Mühlberger A, Andreatta M, Ewald H, Glotzbach-Schoon E, Tröger C, Baumann C, Reif A, Deckert J, Pauli P. 2014. The BDNF Val66Met polymorphism modulates the generalization of cued fear responses to a novel context. Neuropsychopharmacology 39:1187-1195.
109. Munafò MR, Brown SM, Hariri AR. 2008. Serotonin transporter (5-HTTLPR) genotype and amygdala activation: A meta-analysis. Biol Psychiatry 63:852-857.
110. Munafò MR, Matheson IJ, Flint J. 2007. Association of the DRD2 gene Taq1A polymorphism and alcoholism: A meta-analysis of case-control studies and evidence of publication bias. Mol Psychiatry 12:454-461.
111. Murphy SE, Norbury R, Godlewska BR, Cowen PJ, Mannie ZM, Harmer CJ, Munafò MR. 2013. The effect of the serotonin transporter polymorphism (5-HTTLPR) on amygdala function: A meta-analysis. Mol Psychiatry 18:512-520.
112. Norrholm SD, Jovanovic T, Briscione MA, Anderson KM, Kwon CK, Warren VT, Bosshardt L, Bradley B. 2014. Generalization of fear-potentiated startle in the presence of auditory cues: A parametric analysis. Front Behav Neurosci 8:361.
113. Norrholm SD, Jovanovic T, Olin IW, Sands LA, Karapanou I, Bradley B, Ressler KJ. 2011. Fear extinction in traumatized civilians with posttraumatic stress disorder: Relation to symptom severity. Biol Psychiatry 69:556-563.
114. Norrholm SD, Jovanovic T, Smith AK, Binder E, Klengel T, Conneely K, Mercer KB, Davis JS, Kerley K, Winkler J, Gillespie CF, Bradley B, Ressler KJ. 2013. Differential genetic and epigenetic regulation of catechol-O-methyltransferase is associated with impaired fear inhibition in posttraumatic stress disorder. Front Behav Neurosci 7:30.
115. Pape HC, Jüngling K, Seidenbecher T, Lesting J, Reinscheid RK. 2010. Neuropeptide S: A transmitter system in the brain regulating fear and anxiety. Neuropharmacology 58:29-34.
116. Pauli P, Conzelmann A, Mucha RF, Weyers P, Baehne CG, Fallgatter AJ, Jacob CP, Lesch KP. 2010. Affect-modulated startle reflex and dopamine D4 receptor gene variation. Psychophysiology 47:25-33.
117. Pavlov IP. 1927. Conditioned reflexes: an investigation of the physiological activity of the cerebral cortex. London: Oxford University Press.
118. Pezawas L, Meyer-Lindenberg A, Drabant EM, Verchinski BA, Munoz KE, Kolachana BS, Egan MF, Mattay VS, Hariri AR, Weinberger DR. 2005. 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: A genetic susceptibility mechanism for depression. Nat Neurosci 8:828-834.
119. Pezze MA, Feldon J. 2004. Mesolimbic dopaminergic pathways in fear conditioning. Prog Neurobiol 74:301-320.
120. Pohlack ST, Nees F, Ruttorf M, Witt SH, Nieratschker V, Rietschel M, Flor H. 2011. Risk variant for schizophrenia in the neurogranin gene impacts on hippocampus activation during contextual fear conditioning. Mol Psychiatry 16:1072-1073.
121. Potkin SG, Turner JA, Guffanti G, Lakatos A, Fallon JH, Nguyen DD, Mathalon D, Ford J, Lauriello J, Macciardi F, FBIRN . 2009. A genome-wide association study of schizophrenia using brain activation as a quantitative phenotype. Schizophr Bull 35:96-108.
122. Psychiatric GWAS Consortium Bipolar Disorder Working Group . 2011. Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nature Genet 43:977-983.
123. Raczka KA, Gartmann N, Mechias ML, Reif A, Büchel C, Deckert J, Kalisch R. 2010. A neuropeptide S receptor variant associated with overinterpretation of fear reactions: A potential neurogenetic basis for catastrophizing. Mol Psychiatry 15:1067-1074.
124. Raczka KA, Mechias ML, Gartmann N, Reif A, Deckert J, Pessiglione M, Kalisch R. 2011. Empirical support for an involvement of the mesostriatal dopamine system in human fear extinction. Transl Psychiatry 1:e12.
125. Reif A, Richter J, Straube B, Höfler M, Lueken U, Gloster AT, Weber H, Domschke K, Fehm L, Ströhle A, Jansen A, Gerlach A, Pyka M, Reinhardt I, Konrad C, Wittmann A, Pfleiderer B, Alpers GW, Pauli P, Lang T, Arolt V, Wittchen HU, Hamm A, Kircher T, Deckert J. 2014. MAOA and mechanisms of panic disorder revisited: From bench to molecular psychotherapy. Mol Psychiatry 19:122-128.
126. Reinscheid RK, Xu YL, Okamura N, Zeng J, Chung S, Pai R, Wang Z, Civelli O. 2005. Pharmacological characterization of human and murine neuropeptide S receptor variants. J Pharmacol Exp Ther 315:1338-1345.
127. Ressler KJ, Mercer KB, Bradley B, Jovanovic T, Mahan A, Kerley K, Norrholm SD, Kilaru V, Smith AK, Myers AJ, Ramirez M, Engel A, Hammack SE, Toufexis D, Braas KM, Binder EB, May V. 2011. Post-traumatic stress disorder is associated with PACAP and the PAC1 receptor. Nature 470:492-497.
128. Rodrigues SM, Saslow LR, Garcia N, John OP, Keltner D. 2009. Oxytocin receptor genetic variation relates to empathy and stress reactivity in humans. Proc Natl Acad Sci USA 106:21437-21441.
129. Sabol SZ, Hu S, Hamer D. 1998. A functional polymorphism in the monoamine oxidase A gene promoter. Hum Genet 103:273-279.
130. Schiller D, Monfils MH, Raio CM, Johnson DC, Ledoux JE, Phelps EA. 2010. Preventing the return of fear in humans using reconsolidation update mechanisms. Nature 463:49-53.
131. Schizophrenia Working Group of the Psychiatric Genomics Consortium . 2014. Biological insights from 108 schizophrenia-associated genetic loci. Nature 511:421-427.
132. Shen KK, Rose S, Fripp J, McMahon KL, de Zubicaray GI, Martin NG, Thompson PM, Wright MJ, Salvado O. 2014. Investigating brain connectivity heritability in a twin study using diffusion imaging data. Neuroimage 100:628-641.
133. Shin LM, Liberzon I. 2010. The neurocircuitry of fear, stress, and anxiety disorders. Neuropsychopharmacology 35:169-191.
134. Smolka MN, Bühler M, Schumann G, Klein S, Hu XZ, Moayer M, Zimmer A, Wrase J, Flor H, Mann K, Braus DF, Goldman D, Heinz A. 2007. Gene-gene effects on central processing of aversive stimuli. Mol Psychiatry 12:307-317.
135. Smolka MN, Schumann G, Wrase J, Grüsser SM, Flor H, Mann K, Braus DF, Goldman D, Büchel C, Heinz A. 2005. Catechol-O-methyltransferase val158met genotype affects processing of emotional stimuli in the amygdala and prefrontal cortex. J Neurosci 25:836-842.
136. Smoller JW, Gallagher PJ, Duncan LE, McGrath LM, Haddad SA, Holmes AJ, Wolf AB, Hilker S, Block SR, Weill S, Young S, Choi EY, Rosenbaum JF, Biederman J, Faraone SV, Roffman JL, Manfro GG, Blaya C, Hirshfeld-Becker DR, Stein MB, Van Ameringen M, Tolin DF, Otto MW, Pollack MH, Simon NM, Buckner RL, Ongür D, Cohen BM. 2014. The human ortholog of acid-sensing ion channel gene ASIC1a is associated with panic disorder and amygdala structure and function. Biol Psychiatry 76:902-910.
137. Soliman F, Glatt CE, Bath KG, Levita L, Jones RM, Pattwell SS, Jing D, Tottenham N, Amso D, Somerville LH, Voss HU, Glover G, Ballon DJ, Liston C, Teslovich T, Van Kempen T, Lee FS, Casey BJ. 2010. A genetic variant BDNF polymorphism alters extinction learning in both mouse and human. Science 327:863-866.
138. Sotres-Bayon F, Quirk GJ. 2010. Prefrontal control of fear: More than just extinction. Curr Opin Neurobiol 20:231-235.
139. Spradley JM, Guindon J, Hohmann AG. 2010. Inhibitiors of monoacylglycerol lipase, fatty-acid amide hydrolase and endocannabinoid transport differentially suppress capsaicin-induced behavioral sensitization through peripheral endocannabinoid mechanisms. Pharmacol Res. 62:249-258.
140. Stein JL, Medland SE, Vasquez AA, Hibar DP, Senstad RE, Winkler AM, Toro R, Appel K, Bartecek R, Bergmann Ø, Bernard M, Brown AA, Cannon DM, Chakravarty MM, Christoforou A, Domin M, Grimm O, Hollinshead M, Holmes AJ, Homuth G, Hottenga JJ, Langan C, Lopez LM, Hansell NK, Hwang KS, Kim S, Laje G, Lee PH, Liu X, Loth E, Lourdusamy A, Mattingsdal M, Mohnke S, Maniega SM, Nho K, Nugent AC, O'Brien C, Papmeyer M, Pütz B, Ramasamy A, Rasmussen J, Rijpkema M, Risacher SL, Roddey JC, Rose EJ, Ryten M, Shen L, Sprooten E, Strengman E, Teumer A, Trabzuni D, Turner J, van Eijk K, van Erp TG, van Tol MJ, Wittfeld K, Wolf C, Woudstra S, Aleman A, Alhusaini S, Almasy L, Binder EB, Brohawn DG, Cantor RM, Carless MA, Corvin A, Czisch M, Curran JE, Davies G, de Almeida MA, Delanty N, Depondt C, Duggirala R, Dyer TD, Erk S, Fagerness J, Fox PT, Freimer NB, Gill M, Göring HH, Hagler DJ, Hoehn D, Holsboer F, Hoogman M, Hosten N, Jahanshad N, Johnson MP, Kasperaviciute D, Kent JW, Jr, Kochunov P, Lancaster JL, Lawrie SM, Liewald DC, Mandl R, Matarin M, Mattheisen M, Meisenzahl E, Melle I, Moses EK, Mühleisen TW, Nauck M, Nöthen MM, Olvera RL, Pandolfo M, Pike GB, Puls R, Reinvang I, Rentería ME, Rietschel M, Roffman JL, Royle NA, Rujescu D, Savitz J, Schnack HG, Schnell K, Seiferth N, Smith C, Steen VM, Valdés Hernández MC, Van den Heuvel M, van der Wee NJ, Van Haren NE, Veltman JA, Völzke H, Walker R, Westlye LT, Whelan CD, Agartz I, Boomsma DI, Cavalleri GL, Dale AM, Djurovic S, Drevets WC, Hagoort P, Hall J, Heinz A, Jack CR, Jr, Foroud TM, Le Hellard S, Macciardi F, Montgomery GW, Poline JB, Porteous DJ, Sisodiya SM, Starr JM, Sussmann J, Toga AW, Veltman DJ, Walter H, Weiner MW, Alzheimer's Disease Neuroimaging Initiative, Consortium EPIGEN, Consortium IMAGEN, Saguenay Youth Study Group, Bis JC, Ikram MA, Smith AV, Gudnason V, Tzourio C, Vernooij MW, Launer LJ, DeCarli C, Seshadri S, Cohorts for Heart, Aging Research in Genomic Epidemiology Consortium, Andreassen OA, Apostolova LG, Bastin ME, Blangero J, Brunner HG, Buckner RL, Cichon S, Coppola G, de Zubicaray GI, Deary IJ, Donohoe G, de Geus EJ, Espeseth T, Fernández G, Glahn DC, Grabe HJ, Hardy J, Hulshoff Pol HE, Jenkinson M, Kahn RS, McDonald C, McIntosh AM, McMahon FJ, McMahon KL, Meyer-Lindenberg A, Morris DW, Müller-Myhsok B, Nichols TE, Ophoff RA, Paus T, Pausova Z, Penninx BW, Potkin SG, Sämann PG, Saykin AJ, Schumann G, Smoller JW, Wardlaw JM, Weale ME, Martin NG, Franke B, Wright MJ, Thompson PM, Enhancing Neuro Imaging Genetics through Meta-Analysis Consortium . 2012. Identification of common variants associated with human hippocampal and intracranial volumes. Nat Genet 44:552-561.
141. Stevens JS, Almli LM, Fani N, Gutman DA, Bradley B, Norrholm SD, Reiser E, Ely TD, Dhanani R, Glover EM, Jovanovic T, Ressler KJ. 2014. PACAP receptor gene polymorphism impacts fear responses in the amygdala and hippocampus. Proc Natl Acad Sci USA 111:3158-3163.
142. Stevens JS, Jovanovic T, Fani N, Ely TD, Glover EM, Bradley B, Ressler KJ. 2013. Disrupted amygdala-prefrontal functional connectivity in civilian women with posttraumatic stress disorder. J Psychiatr Res 47:1469-1478.
143. Straube B, Reif A, Richter J, Lueken U, Weber H, Arolt V, Jansen A, Zwanzger P, Domschke K, Pauli P, Konrad C, Gerlach AL, Lang T, Fydrich T, Alpers GW, Ströhle A, Wittmann A, Pfleiderer B, Wittchen HU, Hamm A, Deckert J, Kircher T. 2014. The functional -1019C/G HTR1A polymorphism and mechanisms of fear. Transl Psychiatry 4:e490.
144. Sullivan PF. 2007. Spurious genetic associations. Biol Psychiatry 61:1121-1126.
145. Sullivan PF, Daly MJ, O'Donovan M. 2012. Genetic architectures of psychiatric disorders: The emerging picture and its implications. Nat Rev Genet 13:537-551.
146. Surguladze SA, Elkin A, Ecker C, Kalidindi S, Corsico A, Giampietro V, Lawrence N, Deeley Q, Murphy DG, Kucharska-Pietura K, Russell TA, McGuffin P, Murray R, Phillips ML. 2008. Genetic variation in the serotonin transporter modulates neural system-wide response to fearful faces. Genes Brain Behav 7:543-551.
147. Tabbert K, Stark R, Kirsch P, Vaitl D. 2006. Dissociation of neural responses and skin conductance reactions during fear conditioning with and without awareness of stimulus contingencies. Neuroimage 32:761-770.
148. Thomason ME, Henry ML, Paul Hamilton J, Joormann J, Pine DS, Ernst M, Goldman D, Mogg K, Bradley BP, Britton JC, Lindstrom KM, Monk CS, Sankin LS, Louro HM, Gotlib IH. 2010. Neural and behavioral responses to threatening emotion faces in children as a function of the short allele of the serotonin transporter gene. Biol Psychol 85:38-44.
149. Thompson PM, Stein JL, Medland SE, Hibar DP, Vasquez AA, Renteria ME, Toro R, Jahanshad N, Schumann G, Franke B, Wright MJ, Martin NG, Agartz I, Alda M, Alhusaini S, Almasy L, Almeida J, Alpert K, Andreasen NC, Andreassen OA, Apostolova LG, Appel K, Armstrong NJ, Aribisala B, Bastin ME, Bauer M, Bearden CE, Bergmann O, Binder EB, Blangero J, Bockholt HJ, Bøen E, Bois C, Boomsma DI, Booth T, Bowman IJ, Bralten J, Brouwer RM, Brunner HG, Brohawn DG, Buckner RL, Buitelaar J, Bulayeva K, Bustillo JR, Calhoun VD, Cannon DM, Cantor RM, Carless MA, Caseras X, Cavalleri GL, Chakravarty MM, Chang KD, Ching CR, Christoforou A, Cichon S, Clark VP, Conrod P, Coppola G, Crespo-Facorro B, Curran JE, Czisch M, Deary IJ, de Geus EJ, den Braber A, Delvecchio G, Depondt C, de Haan L, de Zubicaray GI, Dima D, Dimitrova R, Djurovic S, Dong H, Donohoe G, Duggirala R, Dyer TD, Ehrlich S, Ekman CJ, Elvsåshagen T, Emsell L, Erk S, Espeseth T, Fagerness J, Fears S, Fedko I, Fernández G, Fisher SE, Foroud T, Fox PT, Francks C, Frangou S, Frey EM, Frodl T, Frouin V, Garavan H, Giddaluru S, Glahn DC, Godlewska B, Goldstein RZ, Gollub RL, Grabe HJ, Grimm O, Gruber O, Guadalupe T, Gur RE, Gur RC, Göring HH, Hagenaars S, Hajek T, Hall GB, Hall J, Hardy J, Hartman CA, Hass J, Hatton SN, Haukvik UK, Hegenscheid K, Heinz A, Hickie IB, Ho BC, Hoehn D, Hoekstra PJ, Hollinshead M, Holmes AJ, Homuth G, Hoogman M, Hong LE, Hosten N, Hottenga JJ, Hulshoff Pol HE, Hwang KS, Jack CR, Jr, Jenkinson M, Johnston C, Jönsson EG, Kahn RS, Kasperaviciute D, Kelly S, Kim S, Kochunov P, Koenders L, Krämer B, Kwok JB, Lagopoulos J, Laje G, Landen M, Landman BA, Lauriello J, Lawrie SM, Lee PH, Le Hellard S, Lemaître H, Leonardo CD, Li CS, Liberg B, Liewald DC, Liu X, Lopez LM, Loth E, Lourdusamy A, Luciano M, Macciardi F, Machielsen MW, Macqueen GM, Malt UF, Mandl R, Manoach DS, Martinot JL, Matarin M, Mather KA, Mattheisen M, Mattingsdal M, Meyer-Lindenberg A, McDonald C, McIntosh AM, McMahon FJ, McMahon KL, Meisenzahl E, Melle I, Milaneschi Y, Mohnke S, Montgomery GW, Morris DW, Moses EK, Mueller BA, Muñoz Maniega S, Mühleisen TW, Müller-Myhsok B, Mwangi B, Nauck M, Nho K, Nichols TE, Nilsson LG, Nugent AC, Nyberg L, Olvera RL, Oosterlaan J, Ophoff RA, Pandolfo M, Papalampropoulou-Tsiridou M, Papmeyer M, Paus T, Pausova Z, Pearlson GD, Penninx BW, Peterson CP, Pfennig A, Phillips M, Pike GB, Poline JB, Potkin SG, Pütz B, Ramasamy A, Rasmussen J, Rietschel M, Rijpkema M, Risacher SL, Roffman JL, Roiz-Santiañez R, Romanczuk-Seiferth N, Rose EJ, Royle NA, Rujescu D, Ryten M, Sachdev PS, Salami A, Satterthwaite TD, Savitz J, Saykin AJ, Scanlon C, Schmaal L, Schnack HG, Schork AJ, Schulz SC, Schür R, Seidman L, Shen L, Shoemaker JM, Simmons A, Sisodiya SM, Smith C, Smoller JW, Soares JC, Sponheim SR, Sprooten E, Starr JM, Steen VM, Strakowski S, Strike L, Sussmann J, Sämann PG, Teumer A, Toga AW, Tordesillas-Gutierrez D, Trabzuni D, Trost S, Turner J, Van den Heuvel M, van der Wee NJ, van Eijk K, van Erp TG, van Haren NE, van 't Ent D, van Tol MJ, Valdés Hernández MC, Veltman DJ, Versace A, Völzke H, Walker R, Walter H, Wang L, Wardlaw JM, Weale ME, Weiner MW, Wen W, Westlye LT, Whalley HC, Whelan CD, White T, Winkler AM, Wittfeld K, Woldehawariat G, Wolf C, Zilles D, Zwiers MP, Thalamuthu A, Schofield PR, Freimer NB, Lawrence NS, Drevets W, Alzheimer's Disease Neuroimaging Initiative, Consortium EPIGEN, Consortium IMAGEN, Saguenay Youth Study (SYS) Group . 2014. The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data. Brain Imaging Behav 8:153-182.
150. Torrents-Rodas D, Fullana MA, Arias B, Bonillo A, Caseras X, Andión O, Mitjans M, Fañanás L, Torrubia R. 2012. Acquisition and generalization of fear conditioning are not modulated by the BDNF-val66met polymorphism in humans. Psychophysiology 49:713-719.
151. Tost H, Kolachana B, Hakimi S, Lemaitre H, Verchinski BA, Mattay VS, Weinberger DR, Meyer-Lindenberg A. 2010. A common allele in the oxytocin receptor gene (OXTR) impacts prosocial temperament and human hypothalamic-limbic structure and function. Proc Natl Acad Sci USA 107:13936-13941.
152. Tupak SV, Reif A, Pauli P, Dresler T, Herrmann MJ, Domschke K, Jochum C, Haas E, Baumann C, Weber H, Fallgatter AJ, Deckert J, Ehlis AC. 2013. Neuropeptide S receptor gene: Fear-specific modulations of prefrontal activation. Neuroimage 66:353-360.
153. Vaidyanathan U, Malone SM, Miller MB, McGue M, Iacono WG. 2014. Heritability and molecular genetic basis of acoustic startle eye blink and affectively modulated startle response: A genome-wide association study. Psychophysiology 51:1285-1299.
154. Varnas K, Halldin C, Hall H. 2004. Autoradiographic distribution of serotonin transporters and receptor subtypes in human brain. Hum Brain Mapp 22:246-260.
155. Walther DJ, Peter JU, Bashammakh S, Hortnagl H, Voits M, Fink H, BaderM .. 2003. Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science 299:76.
156. Wendt J, Neubert J, Lindner K, Ernst FD, Homuth G, Weike AI, Hamm AO. 2014. Advance online publication Genetic influences on the acquisition and inhibition of fear. Int J Psychophysiol. DOI: 10.1016/j.ijpsycho.2014.10.007.
157. Whalen PJ, Shin LM, McInerney SC, Fischer H, Wright CI, Rauch SL. 2001. A functional MRI study of human amygdala responses to facial expressions of fear versus anger. Emotion. 1:70-83.
158. Williams LM, Gatt JM, Grieve SM, Dobson-Stone C, Paul RH, Gordon E, Schofield PR. 2010. COMT Val(108/158) Met polymorphism effects on emotional brain function and negativity bias. Neuroimage 53:918-925.
159. Williams LM, Gatt JM, Schofield PR, Olivieri G, Peduto A, Gordon E. 2009. 'Negativity bias' in risk for depression and anxiety: Brain-body fear circuitry correlates, 5-HTT-LPR and early life stress. Neuroimage 47:804-814.
160. Williams LM, Phillips ML, Brammer MJ, Skerrett D, Lagopoulos J, Rennie C, Bahramali H, Olivieri G, David AS, Peduto A, Gordon E. 2001. Arousal dissociates amygdala and hippocampal fear responses: Evidence from simultaneous fMRI and skin conductance recording. Neuroimage 14:1070-1079.
161. Wolfensberger SP, Veltman DJ, Hoogendijk WJ, Boomsma DI, de Geus EJ. 2008. Amygdala responses to emotional faces in twins discordant or concordant for the risk for anxiety and depression. Neuroimage 41:544-552.
162. Zhou Z, Zhu G, Hariri AR, Enoch MA, Scott D, Sinha R, Virkkunen M, Mash DC, Lipsky RH, Hu XZ, Hodgkinson CA, Xu K, Buzas B, Yuan Q, Shen PH, Ferrell RE, Manuck SB, Brown SM, Hauger RL, Stohler CS, Zubieta JK, Goldman D. 2008. Genetic variation in human NPY expression affects stress response and emotion. Nature 452:997-1001.
163. Zill P, Buttner A, Eisenmenger W, Bondy B, Ackenheil M. 2004. Regional mRNA expression of a second tryptophan hydroxylase isoform in postmortem tissue samples of two human brains. Eur Neuropsychopharmacol 14:282-284.